238 related articles for article (PubMed ID: 36339449)
1. Combining bioinformatics, network pharmacology and artificial intelligence to predict the mechanism of celastrol in the treatment of type 2 diabetes.
Wu M; Zhang Y
Front Endocrinol (Lausanne); 2022; 13():1030278. PubMed ID: 36339449
[TBL] [Abstract][Full Text] [Related]
2. Integrated bioinformatics, network pharmacology, and artificial intelligence to predict the mechanism of celastrol against muscle atrophy caused by colorectal cancer.
Wu M; Zhang Y
Front Genet; 2022; 13():1012932. PubMed ID: 36419834
[TBL] [Abstract][Full Text] [Related]
3. Identification of Metabolism-Related Proteins as Biomarkers of Insulin Resistance and Potential Mechanisms of m
Li YL; Li L; Liu YH; Hu LK; Yan YX
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111057
[TBL] [Abstract][Full Text] [Related]
4. Investigation of candidate genes and mechanisms underlying obesity associated type 2 diabetes mellitus using bioinformatics analysis and screening of small drug molecules.
Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
BMC Endocr Disord; 2021 Apr; 21(1):80. PubMed ID: 33902539
[TBL] [Abstract][Full Text] [Related]
5. The mechanisms of celastrol in treating papillary thyroid carcinoma based on network pharmacology and experiment verification.
Yi J; Tian M; Hu L; Kang N; Ma W; Zhi J; Zheng X; Ruan X; Gao M
Ann Transl Med; 2021 May; 9(10):866. PubMed ID: 34164500
[TBL] [Abstract][Full Text] [Related]
6. Potential Molecular Mechanisms of Ephedra Herb in the Treatment of Nephrotic Syndrome Based on Network Pharmacology and Molecular Docking.
Yao T; Wang Q; Han S; Lu Y; Xu Y; Wang Y
Biomed Res Int; 2022; 2022():9214589. PubMed ID: 35837376
[TBL] [Abstract][Full Text] [Related]
7. Network pharmacology and molecular docking approaches to elucidate the potential compounds and targets of Saeng-Ji-Hwang-Ko for treatment of type 2 diabetes mellitus.
Ko M; Kim Y; Kim HH; Jeong S; Ahn D; Chung SJ; Kim H
Comput Biol Med; 2022 Oct; 149():106041. PubMed ID: 36049411
[TBL] [Abstract][Full Text] [Related]
8. Network pharmacology analysis combined with experimental validation to explore the therapeutic mechanism of Schisandra Chinensis Mixture on diabetic nephropathy.
Ma Y; Deng Y; Li N; Dong A; Li H; Chen S; Zhang S; Zhang M
J Ethnopharmacol; 2023 Feb; 302(Pt A):115768. PubMed ID: 36280016
[TBL] [Abstract][Full Text] [Related]
9. Identification of potential bioactive compounds and mechanisms of GegenQinlian decoction on improving insulin resistance in adipose, liver, and muscle tissue by integrating system pharmacology and bioinformatics analysis.
Cao Z; Zeng Z; Wang B; Liu C; Liu C; Wang Z; Li S
J Ethnopharmacol; 2021 Jan; 264():113289. PubMed ID: 32846191
[TBL] [Abstract][Full Text] [Related]
10. Discovery of CLEC2B as a diagnostic biomarker and screening of celastrol as a candidate drug for psoriatic arthritis through bioinformatics analysis.
Niu M; Yuan J; Yan M; Yang G; Yan Z; Yang X
J Orthop Surg Res; 2023 May; 18(1):390. PubMed ID: 37246213
[TBL] [Abstract][Full Text] [Related]
11. Exploring the mechanism of Celastrol in the treatment of rheumatoid arthritis based on systems pharmacology and multi-omics.
Zeng L; Yu G; Yang K; He Q; Hao W; Xiang W; Long Z; Chen H; Tang X; Sun L
Sci Rep; 2024 Jan; 14(1):1604. PubMed ID: 38238321
[TBL] [Abstract][Full Text] [Related]
12.
Yin M; Zhou L; Ji Y; Lu R; Ji W; Jiang G; Ma J; Song X
Front Endocrinol (Lausanne); 2022; 13():946492. PubMed ID: 35992146
[TBL] [Abstract][Full Text] [Related]
13. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
14. Identification of hub genes related to the progression of type 1 diabetes by computational analysis.
Prashanth G; Vastrad B; Tengli A; Vastrad C; Kotturshetti I
BMC Endocr Disord; 2021 Apr; 21(1):61. PubMed ID: 33827531
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate biomarkers and therapeutic agents for heart failure by bioinformatics analysis.
Kolur V; Vastrad B; Vastrad C; Kotturshetti S; Tengli A
BMC Cardiovasc Disord; 2021 Jul; 21(1):329. PubMed ID: 34218797
[TBL] [Abstract][Full Text] [Related]
16. Exploring the pharmacological components and effective mechanism of Mori Folium against periodontitis using network pharmacology and molecular docking.
Wu Z; Ji X; Shan C; Song J; Zhao J
Arch Oral Biol; 2022 Jul; 139():105391. PubMed ID: 35430443
[TBL] [Abstract][Full Text] [Related]
17. Network Pharmacology and Transcriptomics Reveal the Mechanism of GuaLouQuMaiWan in Treatment of Type 2 Diabetes and Its Active Small Molecular Compound.
Feng J; Zhou Y; Liao L; Yu L; Yuan P; Zhang J
J Diabetes Res; 2022; 2022():2736504. PubMed ID: 36248223
[TBL] [Abstract][Full Text] [Related]
18. Integration of Network Pharmacology and Molecular Docking Technology Reveals the Mechanism of the Therapeutic Effect of Xixin Decoction on Alzheimer's Disease.
Zhang Z; Xu J; Ma S; Lin N; Hou M; Wei M; Li T; Shi J
Comb Chem High Throughput Screen; 2022; 25(10):1785-1804. PubMed ID: 35616676
[TBL] [Abstract][Full Text] [Related]
19. Identification and analysis of hub genes of hypoxia-immunity in type 2 diabetes mellitus.
Li J; Yan N; Li X; He S; Yu X
Front Genet; 2023; 14():1154839. PubMed ID: 37153000
[TBL] [Abstract][Full Text] [Related]
20. The identification of key genes and pathways in hepatocellular carcinoma by bioinformatics analysis of high-throughput data.
Zhang C; Peng L; Zhang Y; Liu Z; Li W; Chen S; Li G
Med Oncol; 2017 Jun; 34(6):101. PubMed ID: 28432618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
